Baker Brothers Advisors - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$92,609,000
+108.5%
1,792,6570.0%0.61%
+140.5%
Q2 2022$44,422,000
+93.3%
1,792,657
+95.5%
0.25%
+90.9%
Q1 2022$22,986,000
-61.3%
916,862
-43.8%
0.13%
-54.3%
Q4 2021$59,394,000
+1053.3%
1,631,266
+441.6%
0.29%
+1156.5%
Q3 2021$5,150,000
-84.7%
301,195
-54.1%
0.02%
-84.2%
Q1 2021$33,650,000
-17.2%
656,7100.0%0.15%
-4.6%
Q4 2020$40,663,000
-17.5%
656,710
-27.0%
0.15%
-22.3%
Q3 2020$49,310,000
-9.3%
899,821
-4.8%
0.20%
-17.9%
Q2 2020$54,388,000
+57.6%
945,221
+10.0%
0.24%
+12.7%
Q1 2020$34,515,000
+18.1%
859,015
+16.2%
0.21%
+37.4%
Q4 2019$29,228,000
+1981.8%
739,016
+257.0%
0.16%
+1450.0%
Q3 2019$1,404,000
-27.1%
207,0290.0%0.01%
-23.1%
Q2 2019$1,925,000
-33.1%
207,0290.0%0.01%
-27.8%
Q1 2019$2,876,000
+27.3%
207,0290.0%0.02%0.0%
Q4 2018$2,259,000
-56.8%
207,029
-50.0%
0.02%
-47.1%
Q3 2018$5,233,000
-4.0%
414,0290.0%0.03%
-17.1%
Q2 2018$5,453,000
-3.2%
414,0290.0%0.04%
-14.6%
Q1 2018$5,631,000
+1828.4%
414,029
+743.9%
0.05%
+1500.0%
Q4 2017$292,000
-19.8%
49,0640.0%0.00%0.0%
Q3 2017$364,000
-20.7%
49,0640.0%0.00%
-25.0%
Q2 2017$459,000
+28.6%
49,0640.0%0.00%
+33.3%
Q1 2017$357,000
-1.7%
49,0640.0%0.00%
-25.0%
Q4 2016$363,000
+22.6%
49,0640.0%0.00%
+33.3%
Q3 2016$296,000
+34.5%
49,0640.0%0.00%
+50.0%
Q2 2016$220,000
+80.3%
49,0640.0%0.00%
+100.0%
Q1 2016$122,000
-69.3%
49,0640.0%0.00%
-66.7%
Q4 2015$397,000
+33.7%
49,0640.0%0.00%0.0%
Q3 2015$297,000
-26.5%
49,0640.0%0.00%
-25.0%
Q2 2015$404,000
+9.2%
49,0640.0%0.00%
+33.3%
Q1 2015$370,000
+8.2%
49,064
-1.9%
0.00%0.0%
Q4 2014$342,000
+52.0%
50,0000.0%0.00%0.0%
Q3 2014$225,000
-23.2%
50,0000.0%0.00%
-25.0%
Q2 2014$293,000
-11.7%
50,0000.0%0.00%0.0%
Q1 2014$332,000
+14.5%
50,0000.0%0.00%0.0%
Q4 2013$290,000
-73.9%
50,000
-75.0%
0.00%
-75.0%
Q3 2013$1,112,000
-79.0%
200,000
-46.7%
0.02%
-84.8%
Q2 2013$5,303,000375,0000.10%
Other shareholders
CHEMOCENTRYX INC shareholders Q2 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,525,900$35,085,0002.37%
BVF INC/IL 1,464,515$20,342,0002.28%
Sio Capital Management, LLC 530,175$7,364,0001.99%
Consonance Capital Management LP 1,666,667$23,150,0001.46%
Texas Children's 58,142$808,0000.98%
Virtus ETF Advisers LLC 26,452$367,0000.78%
WASATCH ADVISORS LP 2,464,664$34,234,0000.37%
Carmignac Gestion 1,965,639$27,303,0000.32%
FARALLON CAPITAL MANAGEMENT LLC 1,500,000$20,835,0000.16%
GSA CAPITAL PARTNERS LLP 91,400$1,270,0000.13%
View complete list of CHEMOCENTRYX INC shareholders